Impact Biotech vs OncoDecipher
Impact Biotech vs OncoDecipher, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Impact Biotech is on 39/100 and OncoDecipher on 43/100.
Where each one leads
Impact Biotech
- funding raised: $2.7M against $1.0M
OncoDecipher
- our overall score: 43/100 against 39/100
At a glance
| Measure | Impact Biotech | OncoDecipher |
|---|---|---|
| What it is | Develops and launches Padeliporfin VTP therapy for solid tumor treatment. | OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability. |
| Category | Life Sciences, Cancer, Therapeutics, Biotech | Life Sciences, Cancer, Oncology, Mutation |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 1996 | 2015 |
| Headquarters | Tel Aviv, Israel | Cambridge, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Impact Biotech | OncoDecipher |
|---|---|---|
| Employees | 42 | Not published |
| Headcount growthLast 12 months | +16.9% | Not published |
| Total funding | $2.7M | $1.0M |
| Latest round | Grant | Seed |
| LinkedIn followers | 1,470 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Impact Biotech | OncoDecipher |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 39/100 | 43/100 |
| Traction | 49/100 | 30/100 |
| Team | Not published | 60/100 |
| Search visibility | 34/100 | 3/100 |
| Quality | 45/100 | 52/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | Not published |
| Domain ratingLink authority, 0-100 | 20/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Impact Biotech | OncoDecipher |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
Impact Biotech vs OncoDecipher: common questions
Which is better, Impact Biotech or OncoDecipher?
On our 0-100 score OncoDecipher rates higher (43/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Impact Biotech and OncoDecipher compare on the numbers?
Impact Biotech leads on funding raised ($2.7M against $1.0M). OncoDecipher leads on our overall score (43/100 against 39/100).
Read the full Impact Biotech review and pricing or the OncoDecipher review and pricing. You can also browse other Impact Biotech alternatives we track.